Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma

Overview of attention for article published in medRxiv, December 2021

Altmetric Badge

Mentioned by

news: 55 news outlets
blogs: 3 blogs
twitter: 191 X users

reddit: 4 Redditors
guideline: 1 clinical guideline source
podcasts: 1 podcast

Readers on

mendeley: 32 Mendeley

So far, Altmetric has seen 3 posts from 3 blogs.

[Preprint] RCT: In symptomatic adults above 18 years positive for SARS-CoV-2, early outpatient treatment with high-titer convalescent plasma significantly reduced hospitalizations.

SPECIALTIES, 08 Jan 2022

Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma …

TWiV 845: COVID-19 clinical update #94 with Dr. Daniel Griffin

This Week in Virology with Vincent Racaniello, 25 Dec 2021

In COVID-19 clinical update #94, Daniel Griffin reviews the FDA EUA for Paxlovid, test to stay in school, immunity after…

Early use of convalescent plasma treatment for COVID-19 helps avoid hospitalization

UMass Med Now, 22 Dec 2021

Results of a clinical trial led by Jonathan M. Gerber, MD, suggest that early use of convalescent plasma treatment for COVID-19…

This page shows the most recent blog posts that mention this research output. Click here to find out how to access more activity.